Purchase Order 36C25024P0030
Award Date
10/1/23
Potential Completion Date
9/30/24
Potential Value
$196K
Federal Agency
Veterans Integrated Service Network 10
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of 10 units of the radiopharmaceutical NEURACEQ at 8.1 mCi per dose, with a total ceiling value of $16,770.00. The period of performance is from December 1, 2023 through November 30, 2024. This award is not set aside and supports the VA's medical imaging...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $1.34 million firm fixed price delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The five year contract is for radiopharmaceutical PET imaging services to be performed in Sterling, Virginia. As the prime contractor, Sofie will provide radiopharmaceutical production and distribution to support positron emission tomography scans for...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of Neuraceq Florbetaben F-18 Injections. The contract has a ceiling value of $427,500.00 and runs through September 30, 2024. The award was made without a set-aside designation, reflecting Sofie's established position as a specialized supplier of radiopharmaceuticals and related services to the VA. Sofie Biosciences, Inc. has extensive...
This is a $29,200 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical NEURACEQ (florbetaben F-18) to support medical imaging services at VA facilities. The contract is part of a larger Indefinite Delivery Vehicle (IDV) held by Sofie with the VA, which facilitates the ongoing procurement of specialized radiopharmaceuticals and related services....
This is a $47,925 firm-fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as IBA Molecular, for the supply of NEURACEQ (florbetaben F-18), a diagnostic radiotracer used for Alzheimer's patient PET imaging. The contract has a period of performance through February 11, 2026, and was awarded on February 12, 2025 without a set-aside designation. Sofie CO. is a for-profit organization that specializes in the development and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA) awarded a $383,846.78 delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc., to provide PET radiopharmaceuticals. The firm fixed price contract runs from April 15, 2022 to April 15, 2023 and will be performed in Sterling, Virginia. PET radiopharmaceuticals are medical imaging radioisotopes that are used with positron emission...
This is a $1,916,610.00 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of FDG and NEURACEQ radiopharmaceuticals, which are critical medical imaging products used for cancer detection and Alzheimer's disease diagnostics. Sofie Biosciences, Inc. is a specialized manufacturer of molecular diagnostics and therapeutics, with a...
This contract was awarded by the Department of Veterans Affairs (VA) Ann Arbor Healthcare System to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $546,843.12 firm-fixed-price purchase order is for the provision of radioactive isotopes and has a completion date of September 30, 2024. This contract was awarded without a set-aside designation and supports the VA's medical imaging and cancer treatment programs for veterans. Sofie CO. is an established supplier of...
This is a $730,800 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of Amyloid Florbetaben Injections, a radiopharmaceutical product, to the VA Healthcare System. The award is not set aside and is a follow-on to a previous sole source contract issued by the VA's Network Contracting Office (NCO) 8 to Sofie for the supply of Neuraceq Florbetaben F-18...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...